In mice with and without CKD, phosphorus levels decreased by an average of 35% by 6 hours after injection with long-acting PTH.
Protein levels found to modify the effect of serum phosphorus with mortality in hemodialysis patients.
Researchers compared the novel iron-based phosphate binder with sevelamer.
Each 0.5 mg/dL increment in phosphorus was associated with a 7% increased risk of anemia.
Researchers tested an intervention that included an educational fair, phosphorus group social, and staff education on phosphate binders.
Researchers observed reduced phosphorus levels in HD patients whose diet restricted intake of phosphorus additives.